BioProtect Ltd

BioProtect Ltd is a leader in radiation protection technology, aiming to protect healthy tissue during radiation oncology treatments. The company provides spacers based on proprietary biodegradable balloon technology, catering to a wide range of clinical applications in the fields of oncology and general surgery. Founded in 2004 in Israel, BioProtect's flagship product, the BioProtect Balloon Implant, aims to safeguard healthy tissue in patients undergoing radiation therapy for prostate cancer. This innovative balloon spacer facilitates safe high-dose radiation therapy, significantly reducing the likelihood of serious and chronic radiation side effects while simultaneously improving biochemical tumor control. Having garnered a $28.00M Venture Round investment on 27 September 2023, the company's investors include TriVentures, KB Investments, Consensus Business Group, MVM Partners, Peregrine Ventures, and Alameda Ventures. This latest investment reflects growing confidence in BioProtect's impactful strides in the healthcare sector.